MyBCTeam

After completing trastuzumab (Herceptin) treatment for HER2-positive breast cancer, there are several potential next steps depending on your specific situation. Your doctor may recommend additional targeted therapies such as:

• Neratinib (Nerlynx)
• Pertuzumab (Perjeta)
• Trastuzumab deruxtecan (Enhertu)
• Tucatinib Show Full Answer

After completing trastuzumab (Herceptin) treatment for HER2-positive breast cancer, there are several potential next steps depending on your specific situation. Your doctor may recommend additional targeted therapies such as:

• Neratinib (Nerlynx)
• Pertuzumab (Perjeta)
• Trastuzumab deruxtecan (Enhertu)
• Tucatinib (Tukysa) Your healthcare team will likely continue monitoring your HER2 levels through testing to ensure treatments have been effective. If tests show low HER2 levels, this indicates good treatment response. However, if levels remain high, your doctor may need to adjust your treatment plan. Many people with HER2-positive breast cancer have favorable outcomes with current treatment options.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

How Early-Stage HER2-Positive Breast Cancer Treatment Has Evolved

Genetic Testing for Breast Cancer: Your Guide